Cover Image
市場調查報告書

MRI系統:醫療設備的開發平台評估

Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 348493
出版日期 內容資訊 英文 303 Pages
訂單完成後即時交付
價格
Back to Top
MRI系統:醫療設備的開發平台評估 Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年12月01日 內容資訊: 英文 303 Pages
簡介

本報告提供MRI (磁振造影) 系統的開發中產品調查分析,以各開發階段比較分析為焦點,提供您包含正在開發開發中產品的主要企業,進行中的臨床試驗相關資訊等系統性資訊。

第1章 目錄

第2章 簡介

  • MRI系統概要

第3章 開發中的產品

  • MRI系統 - 開發中產品:各開發階段
  • MRI系統 - 開發中產品:各市場區隔
  • MRI系統 - 開發中產品:各地區
  • MRI系統 - 開發中產品:法規別
  • MRI系統 - 開發中產品:核准預定日別
  • MRI系統 - 進行中的臨床試驗

第4章 MRI系統 - 正在開發的開發中產品:各企業

  • MRI系統企業 - 開發中產品:各開發階段
  • MRI系統 - 開發中產品:各開發階段

第5章 MRI系統企業與產品概要

  • Advanced MRI Technologies
  • BioMers Products, LLC
  • C4 Imaging, LLC
  • Clear Cut Medical Ltd.
  • GE Healthcare
  • Harvard University
  • Hyper Tech Research, Inc.
  • KinetiCor Inc
  • Koninklijke Philips N.V.
  • Leiden University Medical Center
  • Marvel Medtech, LLC
  • Max-Delbruck-Centrum fur Molekulare Medizin (MDC)
  • MRI Robotics LLC
  • Neurospin
  • Philips Healthcare
  • Prism Clinical Imaging, Inc.
  • Siemens Healthcare
  • The University of Queensland
  • Time Medical, Inc.
  • Tornado Spectral Systems
  • University of California, San Diego
  • University of Colorado
  • University of Louisville
  • University of Minnesota
  • University of Nottingham
  • University of Texas Southwestern Medical Center at Dallas
  • VisionQuest Biomedical, LLC
  • Yeda Research and Development Company Ltd.

第6章 MRI系統 - 最近的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0275EPD

GlobalData's Medical Devices sector report, "Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2016" provides an overview of Magnetic Resonance Imaging Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Magnetic Resonance Imaging Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Magnetic Resonance Imaging Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Magnetic Resonance Imaging Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Magnetic Resonance Imaging Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Magnetic Resonance Imaging Systems Overview

3. Products under Development

  • 3.1. Magnetic Resonance Imaging Systems - Pipeline Products by Stage of Development
  • 3.2. Magnetic Resonance Imaging Systems - Pipeline Products by Segment
  • 3.3. Magnetic Resonance Imaging Systems - Pipeline Products by Territory
  • 3.4. Magnetic Resonance Imaging Systems - Pipeline Products by Regulatory Path
  • 3.5. Magnetic Resonance Imaging Systems - Pipeline Products by Estimated Approval Date
  • 3.6. Magnetic Resonance Imaging Systems - Ongoing Clinical Trials

4. Magnetic Resonance Imaging Systems - Pipeline Products under Development by Companies

  • 4.1. Magnetic Resonance Imaging Systems Companies - Pipeline Products by Stage of Development
  • 4.2. Magnetic Resonance Imaging Systems - Pipeline Products by Stage of Development

5. Magnetic Resonance Imaging Systems Companies and Product Overview

  • 5.1. Advanced MRI Technologies Company Overview
  • 5.2. Aspect Imaging Inc Company Overview
  • 5.3. Boston Children's Hospital Company Overview
  • 5.4. Brigham and Women's Hospital Company Overview
  • 5.5. Butterfly Network, Inc. Company Overview
  • 5.6. C4. Imaging, LLC Company Overview
  • 5.7. Cincinnati Children's Hospital Medical Center Company Overview
  • 5.8. Clear Cut Medical Ltd. Company Overview
  • 5.9. Duke University Company Overview
  • 5.10. Elekta AB Company Overview
  • 5.11. GE Global Research Company Overview
  • 5.12. GE Healthcare Ltd Company Overview
  • 5.13. Harvard University Company Overview
  • 5.14. Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Company Overview
  • 5.15. Hyper Tech Research, Inc. Company Overview
  • 5.16. John Hopkins University Company Overview
  • 5.17. KinetiCor Inc Company Overview
  • 5.18. Koninklijke Philips N.V. Company Overview
  • 5.19. Leiden University Company Overview
  • 5.20. Leiden University Medical Center Company Overview
  • 5.21. Marvel Medtech, LLC Company Overview
  • 5.22. Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Company Overview
  • 5.23. Medical College of Wisconsin Company Overview
  • 5.24. Mitsubishi Electric Corporation Company Overview
  • 5.25. MRI Robotics LLC Company Overview
  • 5.26. Neurospin Company Overview
  • 5.27. New York University School of Medicine Company Overview
  • 5.28. Northwestern University Company Overview
  • 5.29. Oregon Health & Science University Company Overview
  • 5.30. Philips Healthcare Company Overview
  • 5.31. Picofemto LLC Company Overview
  • 5.32. Prism Clinical Imaging, Inc. Company Overview
  • 5.33. Resonance Health Ltd Company Overview
  • 5.34. Siemens Healthcare GmbH Company Overview
  • 5.35. Stanford University Company Overview
  • 5.36. Tel Aviv University Company Overview
  • 5.37. The University of Queensland Company Overview
  • 5.38. Time Medical, Inc. Company Overview
  • 5.39. Tornado Spectral Systems Company Overview
  • 5.40. Toshiba Medical Systems Corporation Company Overview
  • 5.41. University of California Davis Company Overview
  • 5.42. University of California Los Angeles Company Overview
  • 5.43. University of California San Diego Company Overview
  • 5.44. University of Colorado Company Overview
  • 5.45. University of Illinois Company Overview
  • 5.46. University of Illinois at Chicago Company Overview
  • 5.47. University of Louisville Company Overview
  • 5.48. University of Michigan Company Overview
  • 5.49. University of Minnesota Company Overview
  • 5.50. University of Nottingham Company Overview
  • 5.51. University of Texas Southwestern Medical Center Company Overview
  • 5.52. University of Virginia Company Overview
  • 5.53. University of Washington Company Overview
  • 5.54. Vanderbilt University Company Overview
  • 5.55. VisionQuest Biomedical, LLC Company Overview
  • 5.56. Wake Forest Baptist Medical Center Company Overview
  • 5.57. Weinberg Medical Physics, LLC Company Overview
  • 5.58. Weizmann Institute of Science Company Overview

6. Magnetic Resonance Imaging Systems- Recent Developments

  • 6.1. Nov 23, 2016: WristView, Point-of-Care 'Place-Anywhere' Mini MRI System for Wrist and Hand Imaging, Will Be Unveiled by Aspect Imaging at RSNA 2016
  • 6.2. Nov 22, 2016: New era in cancer treatment to begin as Sadiq Khan opens revolutionary radiotherapy machine
  • 6.3. Nov 21, 2016: Enhanced MRI techniques can spot brain tumour growth
  • 6.4. Nov 21, 2016: Researchers Generate 3-D Virtual Reality Models of Unborn Babies
  • 6.5. Nov 14, 2016: ViewRay Reports Third Quarter 2016 Financial Results
  • 6.6. Nov 10, 2016: Monteris Medical Raises USD6.8 Million in Venture Financing
  • 6.7. Nov 09, 2016: Results Published Recommending Use of FerriScan® R2-MRI in Sickle Cell Disease
  • 6.8. Nov 09, 2016: FONAR Announces 1st Quarter Financial Results For Fiscal 2017
  • 6.9. Nov 04, 2016: MRI Interventions Announces 2016 Third Quarter and Nine Month Results
  • 6.10. Nov 03, 2016: T2 Biosystems Announces New Data Demonstrating Clinical and Economic Benefits of T2 Magnetic Resonance Technology in Clinical Settings at IDWeek 2016
  • 6.11. Nov 03, 2016: Alliance HealthCare Services Reports Results for the Third Quarter Ended September 30, 2016
  • 6.12. Nov 02, 2016: Lak Ananth to head new next47 startup unit
  • 6.13. Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016
  • 6.14. Nov 02, 2016: iCAD Reports Third Quarter 2016 Financial Results
  • 6.15. Nov 02, 2016: Bruker Reports Third Quarter 2016 Financial Results
  • 6.16. Nov 02, 2016: MR Solutions' 3T MRI preclinical imaging system aids oncology research at Luxembourg
  • 6.17. Nov 02, 2016: Alliance HealthCare Services Announces Partnership with Signature Healthcare to Offer Expanded MRI, Scheduling and Marketing Services
  • 6.18. Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation
  • 6.19. Oct 28, 2016: SyntheticMR and Siemens Healthineers Sign Cooperation Agreement
  • 6.20. Oct 27, 2016: ContextVision Presents Q3 2016 Financial Report
  • 6.21. Oct 26, 2016: Elisha W. Finney Announces Plan to Retire as CFO of Varian Medical Systems
  • 6.22. Oct 26, 2016: Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2016
  • 6.23. Oct 24, 2016: Philips' Third Quarter Results 2016
  • 6.24. Oct 24, 2016: Analogic Announces Leadership Transition
  • 6.25. Oct 18, 2016: SNPRC scientists develop MRI-guided neural stem cell delivery method
  • 6.26. Oct 18, 2016: Upcoming Webinar to Discuss Functional Brain Imaging Using MRI
  • 6.27. Oct 17, 2016: Profound Medical Raises USD13.2 Million in Public Offering of Shares
  • 6.28. Oct 13, 2016: Imaging with new biomarker tracks tumor progression, response to brain cancer treatment
  • 6.29. Oct 12, 2016: Installation of Elekta's Sixth High-Field MR-adaptive Linear Accelerator Initiated At The Christie
  • 6.30. Oct 12, 2016: Real-time, observable MRI delivery updated to improve stem cell therapy for Parkinson's
  • 6.31. Oct 05, 2016: Mayo Clinic researchers map prostate cancer relapse using C-11 choline PET and MRI
  • 6.32. Sep 30, 2016: C4 Imaging Raises USD1 Million in Venture Financing
  • 6.33. Sep 29, 2016: Data presented at ASTRO underscore the promise of Elekta's high-field MR-adaptive linear accelerator as a transformative advance in radiation therapy
  • 6.34. Sep 25, 2016: Qfix Announces Launch of Insight MRI Overlay and Coil Holders for Siemens MAGNETOM Aera and Skyra
  • 6.35. Sep 23, 2016: Siegfried Russwurm to resign by mutual agreement from the Siemens Management Board
  • 6.36. Sep 21, 2016: Analogic Announces Results for the Fourth Quarter and Fiscal Year Ended July 31, 2016 and Declares Quarterly Cash Dividend
  • 6.37. Sep 20, 2016: Installation initiated for Elekta's high-field MR-adaptive linear accelerator at Froedtert & the Medical College of Wisconsin Clinical Cancer Center
  • 6.38. Sep 19, 2016: FONAR Announces Fiscal 2016 Year End Earnings
  • 6.39. Sep 14, 2016: Fusion targeted prostate biopsy proves more accurate in diagnosis of prostate cancer
  • 6.40. Sep 09, 2016: SyntheticMR AB: MAGiC receives FDA approval
  • 6.41. Sep 08, 2016: iCAD Announces Management Transition
  • 6.42. Sep 07, 2016: Expansion of Involvement in Pharmaceutical Company's Clinical Trial
  • 6.43. Sep 07, 2016: Varian Medical Systems Acquires Radiotherapy Business of Candela
  • 6.44. Sep 05, 2016: Aspect Imaging Introduces its Cost-Effective, Top Quality, Multi-Modality Imaging Tools to Streamline Research
  • 6.45. Sep 01, 2016: Henry Ford Health System Acquires Linear Accelerator Technology from ViewRay
  • 6.46. Sep 01, 2016: Philips appoints Sophie Bechu as Chief of Operations
  • 6.47. Aug 31, 2016: MRI Interventions to Raise USD4.3 Million in Private Placement of Units
  • 6.48. Aug 31, 2016: Bruce Elder Named CEO of MedQuest
  • 6.49. Aug 24, 2016: Concord Medical Reports Financial Results for the First Half of 2016
  • 6.50. Aug 23, 2016: MRI scans may be useful in diagnosing chronic traumatic encephalopathy, UCLA study shows
  • 6.51. Aug 22, 2016: Judy Bruner Appointed to Board of Directors of Varian Medical Systems; Venkatraman Thyagarajan Retires from Varian Board
  • 6.52. Aug 22, 2016: Novel MRI technique distinguishes healthy prostate tissue from cancer using zinc
  • 6.53. Aug 19, 2016: ViewRay to Raise USD13.8 Million in Private Placement of Units
  • 6.54. Aug 18, 2016: ContextVision presents Q2 2016 financial report
  • 6.55. Aug 17, 2016: Celsense Raises USD0.1 Million in Venture Financing
  • 6.56. Aug 16, 2016: Alexandria VA Pineville Healthcare System Becomes First VA Medical Center to Offer Unique Philips Ingenia MRI with in-bore Ambient Experience
  • 6.57. Aug 16, 2016: New MRI Technique Sheds Technology's Longtime Limits
  • 6.58. Aug 15, 2016: InSightec Enters into Partnership with Siemens Healthineers
  • 6.59. Aug 15, 2016: MRI Interventions Announces 2016 Second Quarter and Six Month Results
  • 6.60. Aug 15, 2016: ViewRay Reports Second Quarter 2016 Financial Results
  • 6.61. Aug 05, 2016: Data presentations at AAPM 2016 Highlight Potential of Elekta's High-field MR-linac to Enable Real-time Treatment Adaptation
  • 6.62. Aug 04, 2016: Alliance HealthCare Services Reports Results for the Second Quarter and Six Months Ended June 30, 2016
  • 6.63. Aug 04, 2016: Manchester scientists get £1.47million funding boost for lung cancer research
  • 6.64. Aug 02, 2016: Bruker Reports Second Quarter 2016 Financial Results
  • 6.65. Jul 31, 2016: Toshiba and AHRA Open Applications for Ninth Annual Putting Patients First Program
  • 6.66. Jul 28, 2016: New MRI System Enhances Comfort for Patients at Advocate Good Shepherd Hospital
  • 6.67. Jul 28, 2016: Aspect Imaging and Frog Design Enter Partnership
  • 6.68. Jul 27, 2016: iCAD Reports Second Quarter 2016 Financial Results
  • 6.69. Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016
  • 6.70. Jul 27, 2016: Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2016
  • 6.71. Jul 25, 2016: Philips' Second Quarter Results 2016
  • 6.72. Jul 21, 2016: Varian Medical Systems Announces Company Name For Imaging Components Business
  • 6.73. Jul 20, 2016: Insight Imaging Los Gatos MRI's New Wide-Bore 3T MRI Provides Clearer, High-Quality Exams With Greater Patient Comfort
  • 6.74. Jul 19, 2016: Monteris Medical Announces Appointment Of Martin J. Emerson As President and Chief Executive Officer
  • 6.75. Jul 12, 2016: Philips and Spanish hospital Campus de la Salud start implementation of multi-year strategic partnership agreement
  • 6.76. Jul 08, 2016: New funding for the harmonisation and alignment of brain imaging methods
  • 6.77. Jul 08, 2016: Rush Participating in NIH Precision Medicine Study of 1 Million
  • 6.78. Jul 07, 2016: NIBIB-funded team develops a new way to image fat metabolism
  • 6.79. Jul 07, 2016: Two SwedishAmerican Physician Executives Assume New Positions
  • 6.80. Jul 06, 2016: Celsense Raises Additional USD0.3 Million in Venture Financing
  • 6.81. Jul 05, 2016: Aspect Imaging's WristView MRI System Now Available in Europe
  • 6.82. Jul 01, 2016: BIOTRONIK Pacemakers that Automatically Adapt to MRI Environments Get CE Approval

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Magnetic Resonance Imaging Systems - Pipeline Products by Stage of Development
  • Table 2: Magnetic Resonance Imaging Systems - Pipeline Products by Segment
  • Table 3: Magnetic Resonance Imaging Systems - Pipeline Products by Territory
  • Table 4: Magnetic Resonance Imaging Systems - Pipeline Products by Regulatory Path
  • Table 5: Magnetic Resonance Imaging Systems - Pipeline Products by Estimated Approval Date
  • Table 6: Magnetic Resonance Imaging Systems - Ongoing Clinical Trials
  • Table 7: MRI Systems Companies - Pipeline Products by Stage of Development
  • Table 8: MRI Systems - Pipeline Products by Stage of Development
  • Table 9: Advanced MRI Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: MRI Cerebral Perfusion Imaging Tool - Product Status
  • Table 11: MRI Cerebral Perfusion Imaging Tool - Product Description
  • Table 12: Multiplexed EPI Imaging Sequence - Product Status
  • Table 13: Multiplexed EPI Imaging Sequence - Product Description
  • Table 14: Aspect Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Embrace Neonatal System - Product Status
  • Table 16: Embrace Neonatal System - Product Description
  • Table 17: Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Fetal Neuroimaging - Product Status
  • Table 19: Fetal Neuroimaging - Product Description
  • Table 20: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Magnetic Resonance Elastography - Product Status
  • Table 22: Magnetic Resonance Elastography - Product Description
  • Table 23: MRI - Head And Knee Imaging - Product Status
  • Table 24: MRI - Head And Knee Imaging - Product Description
  • Table 25: Butterfly Network, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Handheld Ultrasound Device - Product Status
  • Table 27: Handheld Ultrasound Device - Product Description
  • Table 28: C4 Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Sirius MRI Marker - Multi-Modality Imaging - Product Status
  • Table 30: Sirius MRI Marker - Multi-Modality Imaging - Product Description
  • Table 31: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Pediatric Cardiovascular MRI - Product Status
  • Table 33: Pediatric Cardiovascular MRI - Product Description
  • Table 34: Clear Cut Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: ClearSight System - Breast Biopsy - Product Status
  • Table 36: ClearSight System - Breast Biopsy - Product Description
  • Table 37: ClearSight System - Colorectal Cancer - Product Status
  • Table 38: ClearSight System - Colorectal Cancer - Product Description
  • Table 39: ClearSight System - Lung Cancer - Product Status
  • Table 40: ClearSight System - Lung Cancer - Product Description
  • Table 41: ClearSight System - Prostate Cancer - Product Status
  • Table 42: ClearSight System - Prostate Cancer - Product Description
  • Table 43: ClearSight System - Skin Cancer - Product Status
  • Table 44: ClearSight System - Skin Cancer - Product Description
  • Table 45: ClearSight System - Thyroid Cancer - Product Status
  • Table 46: ClearSight System - Thyroid Cancer - Product Description
  • Table 47: Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Neuro and Body MRI - Product Status
  • Table 49: Neuro and Body MRI - Product Description
  • Table 50: Next-Generation MRI Scanner - Product Status
  • Table 51: Next-Generation MRI Scanner - Product Description
  • Table 52: Elekta AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: MR-linac System - Product Status
  • Table 54: MR-linac System - Product Description
  • Table 55: GE Global Research Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: MRI Brain Scanner - Product Status
  • Table 57: MRI Brain Scanner - Product Description
  • Table 58: GE Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: 3.0 T Neonatal MRI scanner - Product Status
  • Table 60: 3.0 T Neonatal MRI scanner - Product Description
  • Table 61: MAGiC - Product Status
  • Table 62: MAGiC - Product Description
  • Table 63: Signa Creator - Product Status
  • Table 64: Signa Creator - Product Description
  • Table 65: Signa Explorer - Product Status
  • Table 66: Signa Explorer - Product Description
  • Table 67: SIGNA Pioneer - Product Status
  • Table 68: SIGNA Pioneer - Product Description
  • Table 69: Value MR - Product Status
  • Table 70: Value MR - Product Description
  • Table 71: GE Healthcare Ltd - Ongoing Clinical Trials Overview
  • Table 72: 3.0 T Neonatal MRI scanner - Development of MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit
  • Table 73: Harvard University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Delta Relaxation Enhanced Magnetic Resonance - Product Status
  • Table 75: Delta Relaxation Enhanced Magnetic Resonance - Product Description
  • Table 76: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: GlucoCEST - Product Status
  • Table 78: GlucoCEST - Product Description
  • Table 79: MR Imaging - Neurological Diseases - Product Status
  • Table 80: MR Imaging - Neurological Diseases - Product Description
  • Table 81: Hyper Tech Research, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 82: Magnesium Diboride (MgB2) Magnetic Resonance Imaging (MRI) System - Product Status
  • Table 83: Magnesium Diboride (MgB2) Magnetic Resonance Imaging (MRI) System - Product Description
  • Table 84: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 85: Intravascular Magnetic Resonance Imaging - Product Status
  • Table 86: Intravascular Magnetic Resonance Imaging - Product Description
  • Table 87: MRI-Based Cancer Detection Device - Product Status
  • Table 88: MRI-Based Cancer Detection Device - Product Description
  • Table 89: KinetiCor Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: Prospective Motion Correction Device - Product Status
  • Table 91: Prospective Motion Correction Device - Product Description
  • Table 92: Koninklijke Philips N.V. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 93: Ingenia 1.5T S - Product Status
  • Table 94: Ingenia 1.5T S - Product Description
  • Table 95: Leiden University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 96: Plasma Antenna - Product Status
  • Table 97: Plasma Antenna - Product Description
  • Table 98: Leiden University Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 99: Multi-Information MRI - Product Status
  • Table 100: Multi-Information MRI - Product Description
  • Table 101: Marvel Medtech, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 102: Solada - 4D - Product Status
  • Table 103: Solada - 4D - Product Description
  • Table 104: Solada - AT - Product Status
  • Table 105: Solada - AT - Product Description
  • Table 106: Solada - R - Product Status
  • Table 107: Solada - R - Product Description
  • Table 108: Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 109: Fast Spin Echo MRI System - Product Status
  • Table 110: Fast Spin Echo MRI System - Product Description
  • Table 111: Medical College of Wisconsin Pipeline Products & Ongoing Clinical Trials Overview
  • Table 112: MR based Electrical Impedance Tomography - Breast Cancer - Product Status
  • Table 113: MR based Electrical Impedance Tomography - Breast Cancer - Product Description
  • Table 114: Multi-parametric MR Imaging - Spinal Disc Degeneration - Product Status
  • Table 115: Multi-parametric MR Imaging - Spinal Disc Degeneration - Product Description
  • Table 116: Simultaneous Multislice Imaging - Product Status
  • Table 117: Simultaneous Multislice Imaging - Product Description
  • Table 118: Mitsubishi Electric Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 119: Full-size MRI Scanner - Product Status
  • Table 120: Full-size MRI Scanner - Product Description
  • Table 121: MRI Robotics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 122: MRI-Guided Breast Biopsy Device - Product Status
  • Table 123: MRI-Guided Breast Biopsy Device - Product Description
  • Table 124: Neurospin Pipeline Products & Ongoing Clinical Trials Overview
  • Table 125: 11.7T MRI System - Product Status
  • Table 126: 11.7T MRI System - Product Description
  • Table 127: New York University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • Table 128: Magnetic Resonance Imaging Reconstruction - Product Status
  • Table 129: Magnetic Resonance Imaging Reconstruction - Product Description
  • Table 130: Pediatric MR Imaging - Product Status
  • Table 131: Pediatric MR Imaging - Product Description
  • Table 132: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 133: MRI-Based - Oxygen Extraction Fraction - Product Status
  • Table 134: MRI-Based - Oxygen Extraction Fraction - Product Description
  • Table 135: Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 136: Contrast-Enhanced Magnetic Resonance Imaging - Product Status
  • Table 137: Contrast-Enhanced Magnetic Resonance Imaging - Product Description
  • Table 138: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
  • Table 139: Magnetic Particle Imaging Scanner - Product Status
  • Table 140: Magnetic Particle Imaging Scanner - Product Description
  • Table 141: Multiva 1.5T MRI System - Product Status
  • Table 142: Multiva 1.5T MRI System - Product Description
  • Table 143: Picofemto LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 144: Cliniscan Prostate Support - Product Status
  • Table 145: Cliniscan Prostate Support - Product Description
  • Table 146: Prism Clinical Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 147: Functional Connectivity MRI - Product Status
  • Table 148: Functional Connectivity MRI - Product Description
  • Table 149: Resonance Health Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 150: MRI Based Diagnostic Test - Liver Fibrosis - Product Status
  • Table 151: MRI Based Diagnostic Test - Liver Fibrosis - Product Description
  • Table 152: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 153: MAGNETOM 10.5T System - Product Status
  • Table 154: MAGNETOM 10.5T System - Product Description
  • Table 155: MAGNETOM 11.7T System - Product Status
  • Table 156: MAGNETOM 11.7T System - Product Description
  • Table 157: MAGNETOM 7T MRI - Product Status
  • Table 158: MAGNETOM 7T MRI - Product Description
  • Table 159: MAGNETOM 9.4T Wide Bore MRI System - Product Status
  • Table 160: MAGNETOM 9.4T Wide Bore MRI System - Product Description
  • Table 161: MAGNETOM Avanto 1.5T Tim+Dot Integrated - Product Status
  • Table 162: MAGNETOM Avanto 1.5T Tim+Dot Integrated - Product Description
  • Table 163: MAGNETOM Skyra - Head/Neck 64 - Product Status
  • Table 164: MAGNETOM Skyra - Head/Neck 64 - Product Description
  • Table 165: MAGNETOM Verio 3T Tim+Dot Integrated - Product Status
  • Table 166: MAGNETOM Verio 3T Tim+Dot Integrated - Product Description
  • Table 167: QISS - Product Status
  • Table 168: QISS - Product Description
  • Table 169: Siemens Healthcare GmbH - Ongoing Clinical Trials Overview
  • Table 170: MAGNETOM Avanto 1.5T Tim+Dot Integrated - Assessment of Lung Involvement in Cystic Fibrosis Patients Using 1.5T MR Imaging with Ultrashort Echo Time (UTE) Pulse Sequences
  • Table 171: MAGNETOM Avanto 1.5T Tim+Dot Integrated - Magnetic Resonance Elastography of Cardiac Transplant Rejection
  • Table 172: MAGNETOM Verio 3T Tim+Dot Integrated - Prostate Magnetic Resonance Imaging in Patient With Previous Negative Biopsies (PROMANEG)
  • Table 173: MAGNETOM Verio 3T Tim+Dot Integrated - Usefulness of Sodium MRI in the Presurgical Assessment of Drug-resistant Partial Epilepsy
  • Table 174: MAGNETOM 7T MRI - Assessment of Optic Nerve Radiation in Patients with Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging
  • Table 175: MAGNETOM 7T MRI - Spatial Analysis and Validation of Glioblastoma on 7 T MRI
  • Table 176: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 177: Magnetic Resonance Imaging - Arteriovenous Lesions - Product Status
  • Table 178: Magnetic Resonance Imaging - Arteriovenous Lesions - Product Description
  • Table 179: Magnetic Resonance Imaging - Breast Cancer - Product Status
  • Table 180: Magnetic Resonance Imaging - Breast Cancer - Product Description
  • Table 181: Magnetic Resonance Imaging - Osteoarthritis - Product Status
  • Table 182: Magnetic Resonance Imaging - Osteoarthritis - Product Description
  • Table 183: MRI - Joint Replacements - Product Status
  • Table 184: MRI - Joint Replacements - Product Description
  • Table 185: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 186: NMR Scanner - Product Status
  • Table 187: NMR Scanner - Product Description
  • Table 188: The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
  • Table 189: LC Scan - Product Status
  • Table 190: LC Scan - Product Description
  • Table 191: Time Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 192: 1.5T Breast MR System - Product Status
  • Table 193: 1.5T Breast MR System - Product Description
  • Table 194: Neona - Product Status
  • Table 195: Neona - Product Description
  • Table 196: Tornado Spectral Systems Pipeline Products & Ongoing Clinical Trials Overview
  • Table 197: Magnetic Resonance Imaging - Pelvic Cancer - Product Status
  • Table 198: Magnetic Resonance Imaging - Pelvic Cancer - Product Description
  • Table 199: Toshiba Medical Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 200: Vantage Titan / cS Edition - Product Status
  • Table 201: Vantage Titan / cS Edition - Product Description
  • Table 202: University of California Davis Pipeline Products & Ongoing Clinical Trials Overview
  • Table 203: Diffusion MRI - Neurological Disorders - Product Status
  • Table 204: Diffusion MRI - Neurological Disorders - Product Description
  • Table 205: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • Table 206: Dynamic MR Angiography - Arteriovenous Malformation - Product Status
  • Table 207: Dynamic MR Angiography - Arteriovenous Malformation - Product Description
  • Table 208: Magnetic Resonance Imaging Device - Product Status
  • Table 209: Magnetic Resonance Imaging Device - Product Description
  • Table 210: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
  • Table 211: Aerial Spin Labeling - Product Status
  • Table 212: Aerial Spin Labeling - Product Description
  • Table 213: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
  • Table 214: Myelin Mapping MRI Device - Product Status
  • Table 215: Myelin Mapping MRI Device - Product Description
  • Table 216: Myelin-Mapping MRI System - Product Status
  • Table 217: Myelin-Mapping MRI System - Product Description
  • Table 218: Susceptibility Weighted MR Imaging Device - Product Status
  • Table 219: Susceptibility Weighted MR Imaging Device - Product Description
  • Table 220: University of Illinois Pipeline Products & Ongoing Clinical Trials Overview
  • Table 221: Magnetic Resonance Spectroscopic Imaging - Product Status
  • Table 222: Magnetic Resonance Spectroscopic Imaging - Product Description
  • Table 223: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
  • Table 224: Diagnostic Test - Epilepsy - Product Status
  • Table 225: Diagnostic Test - Epilepsy - Product Description
  • Table 226: University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
  • Table 227: Computer Aided Diagnostic System - Classifying Kidneys - Product Status
  • Table 228: Computer Aided Diagnostic System - Classifying Kidneys - Product Description
  • Table 229: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
  • Table 230: Magnetic Resonance Imaging - Radiation Therapy Planning - Product Status
  • Table 231: Magnetic Resonance Imaging - Radiation Therapy Planning - Product Description
  • Table 232: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
  • Table 233: 3D MRI Flattening Tool - Product Status
  • Table 234: 3D MRI Flattening Tool - Product Description
  • Table 235: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
  • Table 236: PoleStar MRI Scanner - Product Status
  • Table 237: PoleStar MRI Scanner - Product Description
  • Table 238: University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 239: Diagnostic Tool - Brain Tumor - Product Status
  • Table 240: Diagnostic Tool - Brain Tumor - Product Description
  • Table 241: University of Virginia Pipeline Products & Ongoing Clinical Trials Overview
  • Table 242: MRI - Coronary Heart Disease - Product Status
  • Table 243: MRI - Coronary Heart Disease - Product Description
  • Table 244: University of Washington Pipeline Products & Ongoing Clinical Trials Overview
  • Table 245: Diagnostic Imaging Tool - Stroke - Product Status
  • Table 246: Diagnostic Imaging Tool - Stroke - Product Description
  • Table 247: fMRI - Brain disorders - Product Status
  • Table 248: fMRI - Brain disorders - Product Description
  • Table 249: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: Magnetic Resonance Imaging Systems - Pipeline Products by Stage of Development
  • Figure 2: Magnetic Resonance Imaging Systems - Pipeline Products by Segment
  • Figure 3: Magnetic Resonance Imaging Systems - Pipeline Products by Territory
  • Figure 4: Magnetic Resonance Imaging Systems - Pipeline Products by Regulatory Path
  • Figure 5: Magnetic Resonance Imaging Systems - Pipeline Products by Estimated Approval Date
  • Figure 6: Magnetic Resonance Imaging Systems - Ongoing Clinical Trials
Back to Top